Livagen (20mg)

Livagen is a synthetic tetrapeptide (Lys-Glu-Asp-Ala) that interacts directly with chromatin to induce decondensation of tightly packed heterochromatin, unlocking previously silenced genes through epigenetic regulation to reactivate genes crucial for cellular function. With a molecular weight of 461.5 g/mol, it rejuvenates immune cells by activating nucleolar organizer regions and altering acrocentric chromosome association in lymphocytes from aged subjects, resulting in gene expression patterns resembling younger cells. It normalizes chromatin structure in hypertrophic cardiomyopathy models for improved cardiac outcomes, enhances vagus nerve signaling in the gastrointestinal system, inhibits enkephalin-degrading enzymes, and exhibits hepatoprotective and antioxidative properties in liver pathology models.